Sign in

CIK 0001818844

  • Non-accelerated filer
  • Smaller reporting company

Dogwood Therapeutics, Inc.

Sign in to watch
Ticker
DWTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
854314201
Phone
+1 866-620-8655
Business address
44 MILTON AVENUE, ALPHARETTA, GA, 30009
Former names
Virios Therapeutics, Inc., Virios Therapeutics, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-03-05 Duncan Gregory Scott CHIEF EXECUTIVE OFFICER Grant or award · Stock Option (right to buy) +330,000 330,000
2025-12-04 Duncan Gregory Scott CHIEF EXECUTIVE OFFICER Grant or award · Stock Option (right to buy) +460,000 460,000
2025-06-27 Duncan Gregory Scott CHIEF EXECUTIVE OFFICER Grant or award · Stock Option (right to buy) +40,000 40,000
2024-02-26 Duncan Gregory Scott CHIEF EXECUTIVE OFFICER Grant or award · Stock Option (right to buy) +138,835 138,835
2023-08-17 Duncan Gregory Scott CHIEF EXECUTIVE OFFICER Purchase +25,000 $1.25 $31K 57,461
2022-12-12 Duncan Gregory Scott CHIEF EXECUTIVE OFFICER Grant or award · Stock Option (right to buy) +410,000 410,000
2022-12-12 Duncan Gregory Scott CHIEF EXECUTIVE OFFICER Grant or award · Stock Option (right to buy) +480,000 480,000
2022-06-23 Duncan Gregory Scott CHIEF EXECUTIVE OFFICER Grant or award · Stock Option (right to buy) +90,000 90,000
2022-05-23 Duncan Gregory Scott CHIEF EXECUTIVE OFFICER Purchase +7,500 $4.52 $34K 32,461
2021-12-21 Duncan Gregory Scott CHIEF EXECUTIVE OFFICER Purchase +5,000 $5.52 $28K 24,961
2021-06-21 Duncan Gregory Scott CHIEF EXECUTIVE OFFICER Grant or award · Stock Option (right to buy) +60,000 60,000
2021-04-06 Duncan Gregory Scott Chief Executive Officer Purchase +382 $6.36 $2K 19,961
2021-04-05 Duncan Gregory Scott Chief Executive Officer Purchase +15,675 $6.17 $97K 19,579
2021-04-05 Duncan Gregory Scott Chief Executive Officer Purchase +15,675 $6.17 $97K 19,579
2021-01-11 Duncan Gregory Scott Chief Executive Officer Grant or award · Stock Option (right to buy) +21,796 435,921
2021-01-06 Duncan Gregory Scott Chief Executive Officer Exercise or conversion +801 $7.80 $6K 3,904
2021-01-06 Duncan Gregory Scott Chief Executive Officer Exercise or conversion · Warrant to Purchase Common Stock −801 0
2020-12-21 Duncan Gregory Scott Chief Executive Officer Grant or award · Stock Option (right to buy) +414,125 414,125

Page 1 of 1 · 18 trades